跳至主要内容
临床试验/CTRI/2023/12/060743
CTRI/2023/12/060743尚未招募Unknown

Phenotype, clinical profile and treatment eligibility of Hepatitis-B infected patients lying in gray zone in a tertiary care center of Eastern India - an observational study. - NI

I.P.G.M.R, Kolkata0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Hepatitis B patients
  • 1. Age > 18 years
  • 2. Fulfilling Gray zone criteria
  • a) Grey zone A (GZ- A): HBeAg positive, normal ALT levels and serum HBV DNA <106 IU/ml;
  • b) Grey zone B (GZ- B): HBeAg positive, elevated ALT levels and serum HBV DNA <2 × 104 IU/ml;
  • c) Grey zone C (GZ- C): HBeAg negative, normal ALT levels and serum HBV DNA <2 × 10 3 IU/ml;
  • d) Grey zone D (GZ- D): HBeAg negative, elevated ALT levels and serum HBV DNA >2 × 10 3 IU/ml.

排除标准

  • 1. subjects unwilling to give consent
  • 2. subjects on treatment or features of Cirrhosis

研究者

发起方
I.P.G.M.R, Kolkata

相似试验

Clinical, biochemical and liver tissue changes in... | 临床试验